Research with stem cells is actively gaining momentum and generating a great deal of excitement. The major breakthrough of the decade is happening in the field of cellular therapy and their applications. More than 5000 research articles are already published and more than 600 worldwide clinical trials are on their way of completion on the remarkable abilities of cells that replace diseased or damaged cells.
There are many individual factors that are important in determining the right course of medical care plan for those who are suffering from degenerative diseases. Conventionally, for ailments such as spinal cord injury, optic nerve atrophy, stroke, etc. only rehabilitative approach can be specified which cannot reverse the damage associated with the disease. Similarly for diseases such as diabetes, osteoarthritis, etc. pharmacotherapy is generally prescribed; the long-term exposure to which can lead to many harmful side effects. Other therapeutic options such as surgery, organ replacement, etc. for degenerative conditions have numerous drawbacks including high cost of treatment, scarcity of organs, post operative infections, problems in healing, and organ rejections among others.
The scientific advancements made in stem cell research can prove stem cell transplantation as a hassle free option in future that could cease the progression of disease and improve the quality of life.
The ethical guidelines followed by ElixCell are in accordance with the World Medical Association’s (WMA) Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects — “In the treatment of a patient, where proven interventions do not exist or have been ineffective, the physician, may use an unproven intervention if in the physician’s judgment it offers hope of saving life, reestablishing health or alleviating suffering.” -Helsinki Declaration